H-DL-Asp-OMe

H-DL-Asp-OMe is a methyl ester of aspartic acid in which the amino group is acetylated (N-acetyl, H-DL-...), giving a protected amino acid ester with the side-chain carboxylate present as a free acid functionality. The molecule contains a stereogenic center at the α-carbon, and the DL designation indicates a racemic mixture suitable for chiral-independent peptide coupling workflows or as a precursor for stereochemical resolution. The combination of an N-acetylated amine and an esterified C-terminus supports amide bond formation while maintaining controlled reactivity of the side-chain carboxyl group for subsequent derivatization or selective activation. The acid/ester functional set enables downstream transformations to peptide building blocks, protected aspartate derivatives, and process-ready intermediates for fine chemical synthesis.

1. Peptide Coupling Chemistry

H-DL-Asp-OMe is used in peptide synthesis development where an amino acid ester with an N-acetyl-protected nitrogen supports amide bond formation under standard coupling conditions. The α-amino acetyl group and the methyl ester C-terminus provide defined functional handles for sequential conversion into longer peptide chains while the side-chain carboxylic acid can be selectively protected or activated to control chemoselectivity. Racemic stereochemistry can be leveraged for generating aspartate-containing libraries or for producing intermediates that are later converted into stereochemically defined analogs. The resulting aspartyl peptide fragments and protected aspartate building blocks can be carried forward into solid-phase or solution-phase assembly strategies, supporting systematic exploration of sequence-dependent properties.

2. Side-Chain Functionalization

H-DL-Asp-OMe is applicable to side-chain modification workflows that exploit the free aspartic acid carboxyl group for controlled derivatization. The methyl ester C-terminus can be maintained during side-chain protection, coupling, or activation steps, enabling orthogonal functional group strategies that separate side-chain chemistry from peptide-ready termini. DL stereochemistry can simplify early-stage intermediate preparation when stereochemical purity is not yet required, with later resolution or stereoselective conversion applied to the α-center. Functionalized aspartate derivatives derived from this compound can serve as precursors for introducing additional carboxylate derivatives, amide-linked motifs, or constrained side-chain architectures relevant to peptidomimetic construction and biochemical probe design.

3. Protected Amino Acid Intermediate

H-DL-Asp-OMe serves as a practical precursor for preparing protected aspartic acid derivatives used in peptide building block manufacturing and synthetic methodology studies. The N-acetylated amine and methyl ester enable conversion into orthogonally protected forms by targeting the side-chain carboxylic acid for esterification, amidation, or protective-group installation compatible with peptide coupling cycles. The racemic α-center can be retained for process development where stereochemical control is introduced at later stages, such as through chiral resolution of the ester or conversion to a stereochemically enriched intermediate. Downstream products include protected Asp residues suitable for C-terminal activation, fragment coupling, and controlled deprotection sequences in industrial fine chemical synthesis and peptide intermediate preparation.

4. Chemical Biology Probes

H-DL-Asp-OMe can be employed in chemical biology research intermediate preparation where aspartate functionality supports binding-site mimicry and labeling chemistry. The molecule's carboxylate-bearing side chain enables conjugation strategies to introduce linkers, handles for affinity tags, or reactive groups for subsequent bioconjugation, while the protected amine and ester form help manage reactivity during multistep synthesis. Racemic material can be used for generating probe collections for screening of stereochemical effects, followed by refinement using enantiopure analogs when structure-recognition trends are identified. Derived aspartate-containing conjugates can then be incorporated into peptide-like scaffolds for studying protein interactions, enzyme recognition, or receptor-associated binding motifs.

5. Process Chemistry Intermediate

H-DL-Asp-OMe is suitable for process chemistry routes that require stable amino acid ester intermediates with predictable functional group behavior. The methyl ester and N-acetyl protection provide handles for stepwise transformations, including side-chain protection/deprotection planning and conversion to activated species for controlled coupling chemistry. DL stereochemistry can reduce complexity in early manufacturing stages by avoiding immediate chiral control while still enabling downstream stereochemical adjustment through resolution or stereoselective derivatization. The compound thus functions as an industrially relevant aspartate-based intermediate for specialty chemical production, including preparation of peptide building blocks, peptidomimetic precursors, and downstream reagents used in applied peptide science workflows.

1. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

2. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

4. High fat diet and GLP-1 drugs induce pancreatic injury in mice

5. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII